318 related articles for article (PubMed ID: 9732286)
1. Development of approaches to improve cell survival in myoblast transfer therapy.
Qu Z; Balkir L; van Deutekom JC; Robbins PD; Pruchnic R; Huard J
J Cell Biol; 1998 Sep; 142(5):1257-67. PubMed ID: 9732286
[TBL] [Abstract][Full Text] [Related]
2. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
Qu Z; Huard J
Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
[TBL] [Abstract][Full Text] [Related]
3. The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscles.
Petersen ZQ; Huard J
Cell Transplant; 2000; 9(4):503-17. PubMed ID: 11038067
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
5. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
6. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
7. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
8. Gene complementation using myoblast transfer into fetal muscle.
Sopper MM; Hauschka SD; Hoffman E; Ontell M
Gene Ther; 1994 Mar; 1(2):108-13. PubMed ID: 7584065
[TBL] [Abstract][Full Text] [Related]
9. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer into skeletal muscles by isogenic myoblasts.
Huard J; Acsadi G; Jani A; Massie B; Karpati G
Hum Gene Ther; 1994 Aug; 5(8):949-58. PubMed ID: 7948144
[TBL] [Abstract][Full Text] [Related]
12. Limitations of nls beta-galactosidase as a marker for studying myogenic lineage or the efficacy of myoblast transfer.
Yang J; Ontell MP; Kelly R; Watkins SC; Ontell M
Anat Rec; 1997 May; 248(1):40-50. PubMed ID: 9143666
[TBL] [Abstract][Full Text] [Related]
13. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
14. Losartan enhances the success of myoblast transplantation.
Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
16. Human muscular fetal cells: a potential cell source for muscular therapies.
Hirt-Burri N; de Buys Roessingh AS; Scaletta C; Gerber S; Pioletti DP; Applegate LA; Hohlfeld J
Pediatr Surg Int; 2008 Jan; 24(1):37-47. PubMed ID: 17962961
[TBL] [Abstract][Full Text] [Related]
17. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
Hodgetts SI; Grounds MD
Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
[TBL] [Abstract][Full Text] [Related]
18. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
Rando TA; Blau HM
J Cell Biol; 1994 Jun; 125(6):1275-87. PubMed ID: 8207057
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
[TBL] [Abstract][Full Text] [Related]
20. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration.
Urish K; Kanda Y; Huard J
Curr Top Dev Biol; 2005; 68():263-80. PubMed ID: 16125002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
